Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Spiropiperidine derivatives as melanocortin receptor agonists

Spiropiperidine derivatives as melanocortin receptor agonists

US Patent 6410548 · Granted Jun 25, 2002

Estimated economic value: $80,329,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions2025
Method of treating melanocortin-4 receptor pathway-associated disorders2025
Peptide compositions2024
Compounds for treating or inhibiting recurrence of acute myeloid leukemia2024
Inhibitors of cellular metabolic processes2024
5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and meth2024
Method of treating melanocortin-4 receptor-associated disorders in heterozygous 2023
Long-acting co-agonists of the glucagon and GLP-1 receptors2022
Inhibitors of cellular metabolic processes2022
Substituted carbapenems for the treatment of bacterial infections2021
Methods of treating neurological, metabolic, and other disorders using enantiopu2021
Pharmaceutical compositions2021